Xencor Inc

Research Xencor Inc (XNCR) on Bullrun: market cap USD 1.16B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerXNCR
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.16B
• Financial periodFY2025
• RevenueUSD 125.58M
• Revenue growth13.7%
• Net income-USD 91.92M
• Free cash flow-USD 138.27M

Valuation Snapshot

latest market cap is USD 1.16B.

About Xencor Inc

Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases. The company provides Ultomiris to treat patients with atypical hemolytic uremic syndrome, generalized myasthenia gravis, and neuromyelitis optica spectrum disororder; and Monjuvi for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma.

Frequently asked questions

What is Xencor Inc's market cap?

Xencor Inc's market capitalization is USD 1.16B.

What does Xencor Inc do?

Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases.